Learn about our editorial policies In economics, the term diseconomies of scale describes the phenomenon that occurs when a firm experiences increasing marginal costs per additional unit of output.
The consensus outlook from analysts is an Buy trajectory for Bio-Techne, with an average 1-year price target of $82.33, indicating a potential 75.99% downside. Analysts currently favor an Neutral ...